Back
Larimar Therapeutics Stock Price Chart
Hedge fund manager warns about the market ahead
Free book prepares you for the coming uncertainty in the stock market
Sell
41
LRMR
Larimar Therapeutics
Last Price:
6.66
Seasonality Move:
-3.23%
7 Day Trial
ALL ACCESS PASS
$
7
32,481% Growth? Meet Mode Mobile's "EarnPhone"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LRMR is experiencing slight selling pressure.
Larimar Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.76 | Sell |
| 20-day SMA: | 7.8 | Sell |
| 50-day SMA: | 8.35 | Sell |
| 200-day SMA: | 7.45 | Sell |
| 8-day EMA: | 7.57 | Sell |
| 20-day EMA: | 7.77 | Sell |
| 50-day EMA: | 8.01 | Sell |
| 200-day EMA: | 7.33 | Sell |
Larimar Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.18 | Sell |
| Relative Strength Index (14 RSI): | 43.16 | Sell |
| Chaikin Money Flow: | -222091 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.4 - 8.14) | Sell |
| Bollinger Bands (100): | (7.11 - 9.09) | Sell |
Larimar Therapeutics Technical Analysis
| Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Larimar Therapeutics Stock
Is Larimar Therapeutics Stock a Buy?
- Larimar Therapeutics share price is 7.20 while LRMR 8-day simple moving average is 7.76, which is a Sell signal.
- The stock price of LRMR is 7.20 while Larimar Therapeutics 20-day SMA is 7.80, which makes it a Sell.
- Larimar Therapeutics 50-day simple moving average is 8.35 while LRMR share price is 7.20, making it a Sell technically.
- LRMR stock price is 7.20 and Larimar Therapeutics 200-day simple moving average is 7.45, creating a Sell signal.
LRMR Technical Analysis vs Fundamental Analysis
Sell
41
Larimar Therapeutics (LRMR)
is a Sell
Is Larimar Therapeutics a Buy or a Sell?
-
Larimar Therapeutics stock is rated a Sell
The current Larimar Therapeutics [LRMR] share price is $7.20. The Score for LRMR is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
Larimar Therapeutics Stock Info
Market Cap:
459.41M
Price in USD:
7.20
Share Volume:
541.9K
Larimar Therapeutics 52-Week Range
52-Week High:
13.68
52-Week Low:
2.18
Sell
41
Larimar Therapeutics (LRMR)
is a Sell
Larimar Therapeutics Share Price Forecast
-
What is the Larimar Therapeutics stock price today?
The Larimar Therapeutics stock price is 7.20 USD today. -
Will LRMR stock go up or go down?
Larimar Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Larimar Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Larimar Therapeutics is overvalued.
Is Larimar Therapeutics Stock a Buy?
- Larimar Therapeutics share price is 7.20 while LRMR 8-day exponential moving average is 7.57, which is a Sell signal.
- The stock price of LRMR is 7.20 while Larimar Therapeutics 20-day EMA is 7.77, which makes it a Sell.
- Larimar Therapeutics 50-day exponential moving average is 8.01 while LRMR share price is 7.20, making it a Sell technically.
- LRMR stock price is 7.20 and Larimar Therapeutics 200-day simple moving average is 7.33, creating a Sell signal.
Fundamental Analysis of Larimar Therapeutics
Is Larimar Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.15 per share, a decrease this year of $0.69 per share, and a decrease next year of $0.43 per share.
Technical Analysis of Larimar Therapeutics
Should I short Larimar Therapeutics stock?
- LRMR Moving Average Covergence Divergence (MACD) indicator is -0.18, suggesting Larimar Therapeutics is a Sell
- Larimar Therapeutics Relative Strength Index (RSI) is 43.16, which suggest Larimar Therapeutics is oversold
- The Bollinger Bands (25) for Larimar Therapeutics is (7.4 - 8.14), which suggest Larimar Therapeutics is a Sell
- The Bollinger Bands (100) for Larimar Therapeutics is (7.11 - 9.09), which suggest Larimar Therapeutics is a Sell
* Larimar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.